Moderna just had its best day since October. Here's what's going on, and what analysts expect
Analysts pointed to an upcoming health care conference and cancer data study release as potential catalysts for Moderna's ongoing rally.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
